The NADase enzyme CD38: An emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis

Thais Ribeiro Peclat, Bo Shi, John Varga, Eduardo Nunes Chini

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'The NADase enzyme CD38: An emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences